GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 19th Apr 2024 ADXS stock ended at $0.572. This is 0.351% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $0.572 to a day high of $0.600.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2024-04-19 $0.600 $0.600 $0.572 $0.572 2 462
2024-04-18 $0.571 $0.571 $0.500 $0.570 9 360
2024-04-17 $0.650 $0.650 $0.640 $0.646 2 242
2024-04-16 $0.685 $0.685 $0.591 $0.601 4 865
2024-04-15 $0.668 $0.668 $0.607 $0.621 6 112
2024-04-12 $0.668 $0.668 $0.610 $0.668 4 675
2024-04-11 $0.668 $0.668 $0.660 $0.668 2 928
2024-04-10 $0.610 $0.610 $0.610 $0.610 703
2024-04-09 $0.610 $0.610 $0.610 $0.610 731
2024-04-08 $0.668 $0.668 $0.668 $0.668 1 209
2024-04-05 $0.687 $0.700 $0.607 $0.607 10 176
2024-04-04 $0.670 $0.670 $0.607 $0.607 2 638
2024-04-03 $0.640 $0.650 $0.627 $0.627 3 095
2024-04-02 $0.640 $0.650 $0.640 $0.640 2 736
2024-04-01 $0.640 $0.640 $0.640 $0.640 0
2024-03-28 $0.720 $0.720 $0.640 $0.640 16 416
2024-03-27 $0.610 $0.700 $0.536 $0.700 23 871
2024-03-26 $0.622 $0.710 $0.580 $0.710 24 117
2024-03-25 $0.626 $0.630 $0.626 $0.630 4 276
2024-03-22 $0.659 $0.659 $0.535 $0.600 1 831
2024-03-21 $0.640 $0.692 $0.590 $0.590 5 619
2024-03-20 $0.600 $0.600 $0.600 $0.600 366
2024-03-19 $0.600 $0.630 $0.600 $0.622 4 961
2024-03-18 $0.624 $0.624 $0.535 $0.597 24 091
2024-03-15 $0.681 $0.681 $0.605 $0.620 6 201
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT